MeditSimple recently held its inaugural meeting of the AI Ethics Advisory Board, marking a significant step toward ethical AI in healthcare. Committed to prioritising patient well-being while harnessing AI’s potential to streamline healthcare pathways, MeditSimple has established this board to ensure ethical standards are at the forefront of their AI development process.
What is MeditSimple’s AI Ethics Advisory Board?
MeditSimple’s AI Ethics Advisory Board will actively shape AI development, ensuring a balance between innovation and ethical considerations. Their first meeting delved into critical topics, including reliability, accuracy, transparency, informed consent, and privacy in AI-driven care coordination.
Who comprises MeditSimple’s AI Ethics Advisory Board?
MeditSimple has assembled a diverse group of experts, including AI, medical, ethics, technology specialists, both internally and externally. This diversity fosters a comprehensive approach to AI ethics, prevents ethics-washing, and encourages meaningful discussions.
We are committed to maintaining an open dialogue with external experts, fostering a culture of accountability and responsibility in the development and deployment of AI in healthcare.
Our esteemed board members also have no financial interests in MeditSimple. This separation means that the Board’s guidance is solely driven by ethical considerations rather than financial incentives. We are extremely grateful for their time to support our responsible AI development.
The members of the AI Ethics Advisory Board include:
External members in alphabetical order:
- Pr. Nadey Hakim: Surgical Director of the Transplant Unit at Imperial College Hospital in London and General Surgeon, author of “Ethical and Legal Issues in Modern Surgery”
- William Halfpenny: Postdoctoral Research Fellow at UC San Diego in Ophthalmology, with background in Data Science, Engineering and Medicine, researching the intersection of NLP and semantic technologies, former co-President of the Cambridge AI in Medicine Society
- EH: Managing Partner at one of the best strategic consulting firms, leading the technology practice.
- Frederic Josue: CEO of 18M a corporate strategy consulting firm that specialises in brand communication and new technologies, serving clients like Ferrero, BNP Paribas, Technicolor, and Orange. President of the We Are AI Community in Paris.
- Jane Li: Former co-President of the Cambridge AI in Medicine Society, with background in Data Science, Engineering and Medicine, researching the impact of blood groups on Trauma outcomes.
Internal members:
- Laurence Levy: Founder and CEO at MeditSimple
- Mathilde Konczynski: Medical Director at MeditSimple
- Zoya Yasmine: Law Graduate from LSE, Secretary of the Cambridge AI in Medicine Society. Researching the Ethics of AI, Data and Algorithms at the University of Cambridge
Next steps
MeditSimple is committed to transparency and accountability, aiming to publish a report detailing actions taken in response to the Board’s comments. This approach ensures that the AI Ethics Advisory Board actively influences decision-making within MeditSimple.
MeditSimple’s decision to establish an AI Ethics Advisory Board reflects our proactive approach to addressing the ethical challenges associated with AI in healthcare coordination. By assembling a panel of external experts to provide guidance, MeditSimple is setting a precedent for ethical AI development and reinforcing its commitment to the health of its patients.
The AI Ethics Advisory Board will continue to meet to guide MeditSimple in the ethical development and deployment of AI technologies. Their recommendations will play a crucial role in shaping MeditSimple’s AI strategy, ensuring that it aligns with the highest ethical standards.
